查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2004287

α粒子發射裝置市場：2026-2032年全球市場預測（依發射裝置類型、設備類型、供應形式、純度等級、偵測技術、應用和最終用戶分類）

Alpha Emitters Market by Emitter Type, Equipment Type, Delivery Mode, Purity Grade, Detection Technique, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年， α發射體市場價值將達到 12.8 億美元，到 2026 年將成長到 15.2 億美元，到 2032 年將達到 48.1 億美元，年複合成長率為 20.74%。

主要市場統計數據
基準年 2025 12.8億美元
預計年份：2026年 15.2億美元
預測年份 2032 48.1億美元
複合年成長率 (%) 20.74%

對α發射體進行全面介紹，重點在於影響策略決策的科學進展、監管趨勢和操作考量。

α放射性核種已從小眾科學研究對象轉變為臨床、環境、工業和科研領域至關重要的工具。本文概述了當前的技術、監管和商業性格局，重點關注放射性核素生產創新與安全處理、檢測和應用方面不斷變化的需求之間的相互作用。此外，本文還著重介紹了α發射體的價值提案——它們獨特的放射生物學特性使其能夠實現高度局部的能量沉積，​​從而達到治療目的；以及它們獨特的訊號，使其能夠用於有針對性的環境和工業監測。

技術突破、更嚴格的法規以及具有韌性的供應鏈重組所引發的變革性環境變化，正在重新思考α放射性物質的部署。

受技術、政策和需求三者協同作用的影響，α發射體市場格局正在經歷一場變革。同位素生產和發生器設計的突破性進展消除了以往的一些瓶頸，而檢測器靈敏度和特異性的提升則拓展了其在臨床治療和環境監測等領域的應用前景。除了這些技術進步之外，臨床研究人員對標靶α療法的探索以及環境和工業從業者對更精確的檢測能力的需求也日益成長。

到 2025 年，美國貿易措施的累積影響將推動採購體系的重組、對國內生產能力的投資以及一體化供應鏈中的風險緩解。

美國於2025年推出的新關稅措施正在對α粒子排放生態系統產生累積影響，波及臨床、工業和研究領域的相關人員採購計畫、物流和成本結構。進口關稅及相關貿易政策增加了依賴國際供應鏈採購同位素、發生器組件和專用設備的機構的交易複雜性。這些措施迫使採購團隊重新評估總到岸成本，並將與交貨延誤和海關合規相關的風險溢價納入成本。

透過詳細的細分洞察，將應用需求、散熱器類型、儀器模式、供應形式、純度差異和檢測技術連結起來，以實現策略協調。

細分市場洞察揭示了差異化的價值鍊和部署路徑，這對策略規劃至關重要。就應用類別而言，環境監測活動涵蓋空氣監測、土壤採樣和水質監測，在長期監測計畫中，檢測靈敏度和法規遵循往往是優先考慮的因素。工業測試依賴無損檢測和厚度測量，透過可靠的檢測器和標準化的放射性物質源，可以實現快速且可重複的測試。醫療療法，包括鎮痛和標靶α射線療法，優先考慮嚴格的純度和臨床級生產。研發活動涵蓋臨床和臨床前研究，需要靈活的放射源和高純度放射性物質以確保研究條件的可重複性。這些特定應用的需求影響採購優先順序、品質保證措施和技術規格。

實際的區域洞察，揭示了美洲、歐洲、中東和非洲以及亞太地區在採用、生產和監管方面的優先事項有何不同。

區域趨勢凸顯了美洲、歐洲、中東和非洲以及亞太地區在戰略重點和實施路徑上的差異。在美洲，先進的臨床研究中心和工業檢測機構的集中，催生了對高純度放射性物質和精密檢測系統的強勁需求。此外，法規環境日益重視供應穩定性和臨床試驗的完整性。這推動了對國內產能的投資，並促進了學術機構、醫療系統和私營供應商之間的合作夥伴關係，以確保治療方案和監測活動的連續性。

主要企業洞察揭示了透過整合供應鏈、技術平台、知識產權和服務主導的競爭定位實現差異化。

α粒子發射材料領域的競爭格局取決於技術專長、法規遵循經驗以及提供可靠供應鏈的能力。主要企業透過整契約位素生產和發生器製造、檢驗的檢測技術以及全面的合規服務，提供一體化解決方案，脫穎而出。其他企業則專注於特定領域，例如高純度生產流程、可擴展的發生器平台或適用於工業環境的可靠檢測器。生產商、設備製造商和醫療機構之間的策略夥伴關係關係日益普遍，有助於加速臨床試驗進程、協調供應物流物流並建立風險共擔機制。

為行業領導者提供切實可行的建議，以建立具有韌性的供應鏈，加快部署速度，並使創新與合規性和最終用戶需求保持一致。

該行業的領導者應優先考慮一系列切實可行的措施，將機會轉化為永續的競爭優勢。首先，投資建立具有韌性的供應鏈，將策略性庫存管理與國內及近岸生產能力的夥伴關係結合，從而降低跨境中斷和關稅波動帶來的風險。其次，優先考慮合規性和人才儲備，建立經認證的培訓項目、健全的品管體係以及符合不斷變化的監管要求的透明文件記錄流程。

透過高度透明、專家主導的調查方法，結合一手訪談、二手檢驗、跨領域整合和情境分析，得出可靠的見解。

本報告的調查方法結合了原始資料收集、專家訪談和嚴謹的二手資料分析，旨在建構關於α發射體現狀的多維度觀點。原始數據是透過與臨床研究人員、環境監測從業人員、工業測試工程師、設備製造商和監管專家進行結構化對話收集的，以了解實際應用中的限制因素和促進因素。這些觀點與技術文獻、監管指南和公開的技術摘要進行交叉比對，以檢驗推斷出的趨勢和技術能力。

一項旨在實現α發射體應用潛力的決定性整合，強調在能力、合規性、檢驗和夥伴關係方面的合作投資。

總之，α發射體佔據著一個戰略意義重大且技術複雜的領域，其科學潛力與監管和營運現實交織在一起。同位素生產、生成技術和檢測器能力的進步正在拓展其在治療、環境監測、工業測試以及研發等領域的應用範圍，而監管和貿易趨勢也在重塑採購和供應鏈策略。相關人員採取綜合觀點，將技術選擇、合規準備和供應韌性結合，將更有利於將科學機會轉化為可靠的專案成果。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：依發射容器型態分類的α粒子發射容器市場

  • 錒-225
  • 鋂-241
  • 釙-210
  • 鐳-223

第9章：α粒子發射裝置市場：依設備分類

  • 檢測器
    • 充氣式檢測器
    • 閃爍檢測器
    • 固體檢測器
  • 發電機
    • 盒式產生器
    • 列式產生器
  • 輻射源
    • 密封輻射源
    • 開放式輻射源

第10章：α粒子發射容器市場：以交付方式分類

  • 複合材料
  • 液體溶液
    • 緩衝溶液
    • 生理食鹽水
  • 密封輻射源
    • 電鍍散熱器
    • 薄膜散熱器

第11章：以純度等級分類的α粒子發射材料市場

  • 大部分
  • 無載體
  • 無載體

第12章：依檢測技術分類的α粒子發射裝置市場

  • CdZnTe檢測器
  • 高純鍺檢測器
  • 電離室
  • NaI(Tl)閃爍器
  • 塑膠閃爍器
  • 比例計數器
  • 固體檢測器

第13章：α粒子發射裝置市場：依應用領域分類

  • 環境監測
    • 大氣監測
    • 土壤取樣
    • 水質監測
  • 工業測試
    • 無損檢測
    • 厚度測量
  • 藥物治療
    • 緩解疼痛
    • 標靶α射線療法
  • 研究與開發
    • 臨床試驗
    • 臨床前研究

第14章：α粒子發射裝置市場：依最終用戶分類

  • 環保組織
  • 醫院和診所
  • 工業無損檢測服務提供者
  • 研究機構

第15章：α粒子發射容器市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章：α粒子發射裝置市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章：α粒子發射材料市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國α粒子發射容器市場

第19章：中國α粒子發射裝置市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Actinium Pharmaceuticals Inc.
  • Alpha Tau Medical Ltd.
  • Bayer AG
  • Bracco Imaging SpA
  • Cardinal Health, Inc.
  • Fusion Pharmaceuticals Inc.
  • Jubilant Pharma Limited
  • Lantheus Holdings, Inc.
  • Nihon Medi-Physics Co., Ltd.
  • Niowave, Inc.
  • NorthStar Medical Radioisotopes, LLC
  • Novartis AG
  • Orano Med
  • Phoenix LLC
  • RadioMedix Inc.
  • Telix Pharmaceuticals Limited
  • Theragenics Corporation
  • Viewpoint Molecular Targeting Inc.
Product Code: MRR-742BD517A934

The Alpha Emitters Market was valued at USD 1.28 billion in 2025 and is projected to grow to USD 1.52 billion in 2026, with a CAGR of 20.74%, reaching USD 4.81 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.28 billion
Estimated Year [2026] USD 1.52 billion
Forecast Year [2032] USD 4.81 billion
CAGR (%) 20.74%

Comprehensive introduction to alpha emitters highlighting scientific advances, regulatory dynamics, and operational considerations shaping strategic decisions

Alpha-emitting radionuclides have transitioned from niche scientific curiosities into pivotal tools across clinical, environmental, industrial, and research domains. This introduction frames the technical, regulatory, and commercial contours that define the present-day landscape, with attention to the interplay between innovation in radionuclide production and evolving requirements for safe handling, detection, and deployment. It clarifies the value proposition of alpha emitters: the unique radiobiological properties that enable highly localized energy deposition for therapy, and the signature signals that facilitate targeted environmental and industrial monitoring.

Over the last decade, improvements in isotope production pathways, generator technologies, and detector capabilities have reshaped practical access to and use of alpha emitters. Concurrently, regulatory authorities and institutional safety programs have tightened controls around sourcing, transport, and clinical application, creating both friction and opportunity. This introduction establishes the analytical lens used throughout the report: examining technological readiness, supply chain robustness, regulatory alignment, and end-user adoption dynamics. It emphasizes a pragmatic orientation-linking scientific capabilities to operational realities-so that decision-makers can prioritize investments that balance innovation with compliance and patient or environmental safety.

Finally, the introduction outlines how subsequent sections connect to one another. After situating the market forces and technological advances, the narrative proceeds to identify transformative shifts, assess policy-driven trade impacts, extract segmentation-driven insights, and present regional and competitive perspectives. The goal is to provide a cohesive foundation that supports strategic planning, partnership development, and risk mitigation for stakeholders across healthcare, environmental monitoring, industrial testing, and research sectors.

Transformative landscape shifts driven by technological breakthroughs, regulatory tightening, and resilient supply chain realignments reshaping alpha emitter adoption

The alpha emitters landscape is undergoing transformative shifts driven by converging forces in technology, policy, and demand. Breakthroughs in isotope production and generator design have reduced some historical bottlenecks, while advances in detector sensitivity and specificity have expanded feasible use cases in both clinical therapy and environmental surveillance. These technological improvements are complemented by increasing interest from clinical researchers exploring targeted alpha therapies, and from environmental and industrial practitioners seeking higher-fidelity detection capabilities.

Regulatory evolution is a parallel vector of change. Legislators and oversight bodies have responded to both safety concerns and therapeutic potential by tightening controls over transport, licensure, and clinical use. As a result, organizations are investing in compliance infrastructures, specialized handling protocols, and workforce training to meet more rigorous standards. This regulatory tightening, while introducing short-term complexity, is also raising overall confidence among institutional stakeholders and enabling more structured clinical trial programs and monitoring initiatives.

Supply chain dynamics constitute a third major shift. Greater attention to secure sourcing, onshoring, and diversification of production pathways is reshaping procurement strategies. Public and private actors alike are prioritizing resilient supply chains to reduce exposure to single-source vulnerabilities, particularly for high-value emitters used in therapy. Taken together, these technological, regulatory, and supply-chain shifts are transforming alpha emitters from specialized research inputs into strategically managed assets, prompting organizations to rethink partnerships, capital allocation, and long-term roadmaps.

Cumulative outcomes of United States trade measures in 2025 driving procurement reconfiguration, domestic capacity investment, and integrated supply chain risk mitigation

The introduction of new tariff measures in the United States in 2025 has had a cumulative influence on the alpha emitters ecosystem, affecting procurement planning, logistics, and cost structures for stakeholders across clinical, industrial, and research settings. Import duties and related trade policies have increased the transactional complexity for organizations that depend on international supply chains for isotopes, generator components, and specialized equipment. These measures have prompted procurement teams to reassess total landed cost considerations and to internalize risk premiums for delayed deliveries and customs-related compliance.

In response, some actors accelerated near-term investments in domestic production capabilities and strategic inventories to buffer against cross-border uncertainties. Such responses streamline continuity for critical clinical programs and industrial operations, but they also require capital and operational investments that alter deployment timelines and purchasing cycles. At the same time, tariff-driven cost pressures incentivized greater collaboration between suppliers and end users to negotiate supply agreements that incorporate shared risk mitigants, such as consignment models, scheduled replenishments, and joint investments in generator systems designed for longer in-field lifetime.

From an operational perspective, organizations recalibrated sourcing strategies, favoring suppliers with established logistics networks and transparent compliance practices. Many institutions intensified due diligence on vendor provenance, certificate-of-origin documentation, and customs handling capabilities. Overall, the 2025 tariff changes catalyzed a reorientation from transactional procurement toward integrated supply-chain partnerships, encouraging investments in domestic capabilities and more robust contractual safeguards to ensure continuity of clinical therapies, environmental monitoring programs, and industrial testing activities.

Deep segmentation insights connecting application needs, emitter types, equipment modalities, delivery formats, purity distinctions, and detection technologies for strategic alignment

Segmentation insights reveal differentiated value chains and adoption pathways that are essential for strategic planning. Considering application categories, environmental monitoring activities span air monitoring, soil sampling, and water monitoring and tend to prioritize detection sensitivity and regulatory compliance for long-term surveillance programs; industrial testing relies on non-destructive testing and thickness gauging where rugged detectors and standardized sources enable rapid, repeatable inspections; medical therapy encompasses pain palliation and targeted alpha therapy where stringent purity and clinical-grade production are paramount; research and development efforts cover clinical trials and preclinical research and demand both flexible sources and high-purity emitters for reproducible study conditions. These application-specific requirements shape procurement priorities, quality assurance practices, and technical specifications.

End-user perspectives further refine these distinctions. Environmental agencies emphasize regulatory alignment and community safety in monitoring deployments, hospitals and clinics focus on clinical workflows, dosimetry, and patient outcomes, industrial non-destructive testing providers prioritize operational throughput and equipment reliability, and research institutes require customizable sources and detection solutions to support experimental protocols. Each end user brings distinct expectations for supplier transparency, training, and after-sales support.

Emitter type selection is another pivotal segmentation axis. Actinium-225, Americium-241, Polonium-210, and Radium-223 each present unique production, handling, and application profiles that influence supply chain design and clinical or industrial adoption. Equipment type choices-detectors, generators, and sources-are differentiated by technical subtypes: detectors include gas-filled detectors, scintillation detectors, and solid state detectors; generators are available as cartridge generators or column generators; sources can be sealed or unsealed. These equipment distinctions affect operational workflows, maintenance regimes, and regulatory classification.

Delivery mode and formulation drive usability considerations. Composite materials, liquid solutions, and sealed sources represent different handling paradigms, and liquid solutions divided into buffered and saline formulations influence compatibility with clinical delivery systems. Sealed sources that are electroplated or manufactured as thin-film sources offer differing lifetimes and radiation profiles suited to industrial and calibration needs. Purity grade further stratifies the market into bulk, carrier-free, and no-carrier-added grades, each reflecting trade-offs between yield, chemical behavior, and suitability for therapeutic or analytical applications. Detection technique choices-spanning CdZnTe detectors, HPGe detectors, ionization chambers, NaI(Tl) scintillators, plastic scintillators, proportional counters, and solid state detectors-determine measurement precision, energy resolution, and operational complexity, directly informing capital expenditure and operational training requirements.

Synthesizing these segmentation dimensions highlights how technical characteristics, regulatory constraints, and end-user workflows coalesce to create distinct submarkets. Strategic decisions should therefore account for cross-segmentation interactions, such as how emitter type and purity grade inform generator selection and clinical applicability, or how detection technique and equipment form factor determine feasibility for field-based environmental monitoring versus centralized laboratory analysis.

Actionable regional insights illuminating how the Americas, Europe, Middle East & Africa, and Asia-Pacific exhibit distinct priorities for adoption, production, and regulation

Regional dynamics accentuate differing strategic priorities and execution pathways across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, a concentration of advanced clinical research centers and industrial testing providers creates robust demand for high-purity emitters and sophisticated detection systems, alongside a regulatory environment that increasingly emphasizes supply security and clinical trial integrity. This drives investment in domestic capabilities and collaborative partnerships between academic centers, healthcare systems, and commercial suppliers to ensure continuity of therapeutic programs and monitoring initiatives.

Across Europe, Middle East & Africa, regulatory harmonization and cross-border cooperation influence procurement approaches, with a focus on standardized safety protocols and interoperable instrumentation that can be deployed across diverse jurisdictions. Regional initiatives that prioritize public health surveillance and environmental protection create steady demand for monitoring solutions, while certain markets in the Middle East and Africa pursue capacity building in clinical and industrial radioisotope use through targeted investments and knowledge-transfer partnerships.

In the Asia-Pacific region, rapid growth in clinical research activity and industrial modernization is prompting accelerated adoption of targeted therapies and advanced detection technologies. Many countries in the region are expanding local production capabilities and investing in training programs to support safe handling and clinical deployment. Supply chain diversification remains a regional priority, with governments and private actors seeking to reduce dependency on single-source imports and to cultivate domestic expertise in isotope production and generator manufacturing.

Taken together, these regional insights underscore the importance of aligning commercial strategies with localized regulatory frameworks, clinical and industrial priorities, and capacity-building trajectories. Organizations should therefore tailor go-to-market and partnership approaches to reflect each region's specific mix of demand drivers, infrastructure maturity, and policy environment.

Key company insights revealing differentiation through integrated supply chains, technology platforms, intellectual property, and service-led competitive positioning

Competitive dynamics in the alpha emitters domain are defined by a combination of technical expertise, regulatory experience, and the ability to deliver reliable supply chains. Leading actors differentiate themselves through integrated offerings that pair isotope production or generator manufacturing with validated detection technologies and comprehensive compliance services. Others focus on specialization-whether in high-purity production routes, scalable generator platforms, or ruggedized detectors for industrial environments. Strategic partnerships between producers, instrument manufacturers, and healthcare institutions are increasingly common, enabling expedited clinical trials, coordinated supply logistics, and shared risk structures.

In addition to vertical integration and partnerships, companies are investing in intellectual property around generator design, source encapsulation techniques, and detector materials to secure competitive advantage. Service capabilities such as training, after-sales maintenance, and regulatory support are central to value propositions, particularly for end users with limited in-house nuclear expertise. Furthermore, firms that can demonstrate robust quality management systems and traceable chain-of-custody procedures tend to gain preference in procurement decisions, as buyers prioritize safety and compliance alongside technical performance.

Market entrants face high technical and regulatory barriers, so successful growth strategies typically combine focused R&D investments with targeted alliances and pilot programs that validate performance in real-world clinical or industrial settings. Ultimately, competitive success will depend on the ability to integrate technical excellence with operational reliability, transparent compliance practices, and strong customer support models.

Actionable recommendations for industry leaders to build resilient supply chains, accelerate adoption, and align innovation with compliance and end-user needs

Leaders in the field should pursue a set of actionable priorities to convert opportunity into durable advantage. First, invest in resilient supply architectures that blend strategic inventory management with partnerships for domestic and nearshore production capabilities, thereby reducing exposure to cross-border disruptions and tariff-related volatility. Second, prioritize compliance and workforce readiness by building accredited training programs, robust quality control systems, and transparent documentation practices that align with evolving regulatory expectations.

Third, accelerate clinical and industrial adoption by funding targeted pilot programs and real-world validation studies that demonstrate safety, efficacy, and operational benefits. Such evidence will expedite institutional buy-in and inform procurement specifications. Fourth, design modular product and service offerings that accommodate diverse end-user needs-from field-deployable detection kits for environmental agencies to clinical-grade generators and liquid formulations for therapeutic programs-so that customers can scale solutions as their requirements evolve.

Fifth, cultivate partnerships across the value chain, including alliances with research institutions, instrumentation manufacturers, and logistics specialists, to co-develop solutions that address cross-functional constraints. Finally, commit to continuous innovation in detector materials, generator efficiency, and source encapsulation technologies while maintaining transparent communication about supply provenance and safety practices. Implementing these priorities will enable organizations to reduce risk, accelerate adoption, and capture strategic opportunities as the ecosystem matures.

Transparent, expert-driven research methodology integrating primary interviews, secondary validation, cross-segmentation synthesis, and scenario analysis for robust insights

The research methodology underpinning this report combines primary intelligence gathering, expert interviews, and rigorous secondary analysis to construct a multi-dimensional view of the alpha emitters landscape. Primary inputs include structured conversations with clinical researchers, environmental monitoring practitioners, industrial test engineers, equipment manufacturers, and regulatory specialists to capture real-world constraints and adoption drivers. These perspectives are triangulated with technical literature, regulatory guidance, and publicly available technical briefs to validate inferred trends and technological capabilities.

Analytical approaches emphasize cross-segmentation synthesis, examining how application requirements, emitter types, equipment modalities, delivery formats, purity grades, and detection techniques interact to produce distinct operational needs. The methodology also accounts for policy and trade influences, using scenario analysis to explore how tariff changes, regulatory updates, and supply chain disruptions could affect procurement and deployment strategies. Quality assurance steps include cross-verification of technical claims, review by subject-matter experts, and systematic documentation of assumptions to ensure traceability and reproducibility of findings.

Transparency about limitations is central to the methodology. Where public data are limited, estimates are informed by expert consensus and corroborated through multiple independent sources. The approach favors actionable insights over speculative assertions and is designed to equip decision-makers with clear, defensible reasoning that can be applied to strategy development, procurement planning, and collaborative initiatives.

Conclusive synthesis emphasizing coordinated investments in capacity, compliance, validation, and partnerships to realize the promise of alpha emitter applications

In conclusion, alpha emitters occupy a strategically important and technically complex domain where scientific potential intersects with regulatory and operational realities. Advances in isotope production, generator technologies, and detector capabilities are expanding feasible applications in therapy, environmental monitoring, industrial testing, and research, while regulatory and trade developments are reshaping procurement and supply-chain strategies. Stakeholders that adopt an integrated view-aligning technical selection, compliance readiness, and supply resilience-will be better positioned to translate scientific opportunity into reliable programmatic outcomes.

The journey from innovation to routine application requires coordinated action across multiple dimensions: investing in capacity and training, establishing resilient sourcing and logistics, validating performance through pilots and trials, and building trust through transparent quality and compliance practices. By focusing on these priorities and leveraging partnerships across the value chain, organizations can mitigate risk, accelerate adoption, and ensure that alpha emitters deliver their intended clinical, environmental, and industrial benefits in a safe and sustainable manner.

This conclusion invites stakeholders to use the detailed insights in the full report to inform strategic choices, operational investments, and collaborative initiatives that will determine how this technology fulfills its promise in the years ahead.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Alpha Emitters Market, by Emitter Type

  • 8.1. Actinium-225
  • 8.2. Americium-241
  • 8.3. Polonium-210
  • 8.4. Radium-223

9. Alpha Emitters Market, by Equipment Type

  • 9.1. Detectors
    • 9.1.1. Gas-Filled Detectors
    • 9.1.2. Scintillation Detectors
    • 9.1.3. Solid State Detectors
  • 9.2. Generators
    • 9.2.1. Cartridge Generators
    • 9.2.2. Column Generators
  • 9.3. Sources
    • 9.3.1. Sealed Sources
    • 9.3.2. Unsealed Sources

10. Alpha Emitters Market, by Delivery Mode

  • 10.1. Composite Materials
  • 10.2. Liquid Solutions
    • 10.2.1. Buffered Solutions
    • 10.2.2. Saline Solutions
  • 10.3. Sealed Sources
    • 10.3.1. Electroplated Sources
    • 10.3.2. Thin-Film Sources

11. Alpha Emitters Market, by Purity Grade

  • 11.1. Bulk
  • 11.2. Carrier-Free
  • 11.3. No-Carrier-Added

12. Alpha Emitters Market, by Detection Technique

  • 12.1. CdZnTe Detectors
  • 12.2. HPGe Detectors
  • 12.3. Ionization Chambers
  • 12.4. NaI(Tl) Scintillators
  • 12.5. Plastic Scintillators
  • 12.6. Proportional Counters
  • 12.7. Solid State Detectors

13. Alpha Emitters Market, by Application

  • 13.1. Environmental Monitoring
    • 13.1.1. Air Monitoring
    • 13.1.2. Soil Sampling
    • 13.1.3. Water Monitoring
  • 13.2. Industrial Testing
    • 13.2.1. Non-Destructive Testing
    • 13.2.2. Thickness Gauging
  • 13.3. Medical Therapy
    • 13.3.1. Pain Palliation
    • 13.3.2. Targeted Alpha Therapy
  • 13.4. Research & Development
    • 13.4.1. Clinical Trials
    • 13.4.2. Preclinical Research

14. Alpha Emitters Market, by End User

  • 14.1. Environmental Agencies
  • 14.2. Hospitals & Clinics
  • 14.3. Industrial Non-Destructive Testing Providers
  • 14.4. Research Institutes

15. Alpha Emitters Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Alpha Emitters Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Alpha Emitters Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Alpha Emitters Market

19. China Alpha Emitters Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Actinium Pharmaceuticals Inc.
  • 20.6. Alpha Tau Medical Ltd.
  • 20.7. Bayer AG
  • 20.8. Bracco Imaging S.p.A.
  • 20.9. Cardinal Health, Inc.
  • 20.10. Fusion Pharmaceuticals Inc.
  • 20.11. Jubilant Pharma Limited
  • 20.12. Lantheus Holdings, Inc.
  • 20.13. Nihon Medi-Physics Co., Ltd.
  • 20.14. Niowave, Inc.
  • 20.15. NorthStar Medical Radioisotopes, LLC
  • 20.16. Novartis AG
  • 20.17. Orano Med
  • 20.18. Phoenix LLC
  • 20.19. RadioMedix Inc.
  • 20.20. Telix Pharmaceuticals Limited
  • 20.21. Theragenics Corporation
  • 20.22. Viewpoint Molecular Targeting Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ALPHA EMITTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ALPHA EMITTERS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ALPHA EMITTERS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ALPHA EMITTERS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ALPHA EMITTERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES ALPHA EMITTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA ALPHA EMITTERS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ALPHA EMITTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ACTINIUM-225, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ACTINIUM-225, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ACTINIUM-225, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ALPHA EMITTERS MARKET SIZE, BY AMERICIUM-241, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ALPHA EMITTERS MARKET SIZE, BY AMERICIUM-241, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ALPHA EMITTERS MARKET SIZE, BY AMERICIUM-241, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ALPHA EMITTERS MARKET SIZE, BY POLONIUM-210, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ALPHA EMITTERS MARKET SIZE, BY POLONIUM-210, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ALPHA EMITTERS MARKET SIZE, BY POLONIUM-210, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RADIUM-223, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RADIUM-223, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RADIUM-223, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DETECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DETECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DETECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GAS-FILLED DETECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GAS-FILLED DETECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GAS-FILLED DETECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SCINTILLATION DETECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SCINTILLATION DETECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SCINTILLATION DETECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOLID STATE DETECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOLID STATE DETECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOLID STATE DETECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GENERATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GENERATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GENERATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CARTRIDGE GENERATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CARTRIDGE GENERATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CARTRIDGE GENERATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COLUMN GENERATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COLUMN GENERATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COLUMN GENERATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOURCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOURCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOURCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ALPHA EMITTERS MARKET SIZE, BY UNSEALED SOURCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ALPHA EMITTERS MARKET SIZE, BY UNSEALED SOURCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ALPHA EMITTERS MARKET SIZE, BY UNSEALED SOURCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COMPOSITE MATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COMPOSITE MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COMPOSITE MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ALPHA EMITTERS MARKET SIZE, BY BUFFERED SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ALPHA EMITTERS MARKET SIZE, BY BUFFERED SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ALPHA EMITTERS MARKET SIZE, BY BUFFERED SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SALINE SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SALINE SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SALINE SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ELECTROPLATED SOURCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ELECTROPLATED SOURCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ELECTROPLATED SOURCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ALPHA EMITTERS MARKET SIZE, BY THIN-FILM SOURCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ALPHA EMITTERS MARKET SIZE, BY THIN-FILM SOURCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ALPHA EMITTERS MARKET SIZE, BY THIN-FILM SOURCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ALPHA EMITTERS MARKET SIZE, BY BULK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ALPHA EMITTERS MARKET SIZE, BY BULK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ALPHA EMITTERS MARKET SIZE, BY BULK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CARRIER-FREE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CARRIER-FREE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CARRIER-FREE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NO-CARRIER-ADDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NO-CARRIER-ADDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NO-CARRIER-ADDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CDZNTE DETECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CDZNTE DETECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CDZNTE DETECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ALPHA EMITTERS MARKET SIZE, BY HPGE DETECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ALPHA EMITTERS MARKET SIZE, BY HPGE DETECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ALPHA EMITTERS MARKET SIZE, BY HPGE DETECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ALPHA EMITTERS MARKET SIZE, BY IONIZATION CHAMBERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ALPHA EMITTERS MARKET SIZE, BY IONIZATION CHAMBERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ALPHA EMITTERS MARKET SIZE, BY IONIZATION CHAMBERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NAI(TL) SCINTILLATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NAI(TL) SCINTILLATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NAI(TL) SCINTILLATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PLASTIC SCINTILLATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PLASTIC SCINTILLATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PLASTIC SCINTILLATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PROPORTIONAL COUNTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PROPORTIONAL COUNTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PROPORTIONAL COUNTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOLID STATE DETECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOLID STATE DETECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOLID STATE DETECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ALPHA EMITTERS MARKET SIZE, BY AIR MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ALPHA EMITTERS MARKET SIZE, BY AIR MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ALPHA EMITTERS MARKET SIZE, BY AIR MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOIL SAMPLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOIL SAMPLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOIL SAMPLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ALPHA EMITTERS MARKET SIZE, BY WATER MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ALPHA EMITTERS MARKET SIZE, BY WATER MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ALPHA EMITTERS MARKET SIZE, BY WATER MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NON-DESTRUCTIVE TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NON-DESTRUCTIVE TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NON-DESTRUCTIVE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ALPHA EMITTERS MARKET SIZE, BY THICKNESS GAUGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ALPHA EMITTERS MARKET SIZE, BY THICKNESS GAUGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ALPHA EMITTERS MARKET SIZE, BY THICKNESS GAUGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PAIN PALLIATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PAIN PALLIATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PAIN PALLIATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL ALPHA EMITTERS MARKET SIZE, BY TARGETED ALPHA THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ALPHA EMITTERS MARKET SIZE, BY TARGETED ALPHA THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ALPHA EMITTERS MARKET SIZE, BY TARGETED ALPHA THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CLINICAL TRIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CLINICAL TRIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PRECLINICAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PRECLINICAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL ALPHA EMITTERS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL ALPHA EMITTERS MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL ALPHA EMITTERS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL NON-DESTRUCTIVE TESTING PROVIDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL NON-DESTRUCTIVE TESTING PROVIDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL NON-DESTRUCTIVE TESTING PROVIDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL ALPHA EMITTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 163. AMERICAS ALPHA EMITTERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 164. AMERICAS ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. AMERICAS ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. AMERICAS ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 167. AMERICAS ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2032 (USD MILLION)
  • TABLE 168. AMERICAS ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2032 (USD MILLION)
  • TABLE 169. AMERICAS ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 170. AMERICAS ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 171. AMERICAS ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2032 (USD MILLION)
  • TABLE 172. AMERICAS ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 173. AMERICAS ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 174. AMERICAS ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. AMERICAS ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 176. AMERICAS ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 177. AMERICAS ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 178. AMERICAS ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 179. AMERICAS ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2032 (USD MILLION)
  • TABLE 186. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 188. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 190. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 194. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 196. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2032 (USD MILLION)
  • TABLE 202. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 204. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2032 (USD MILLION)
  • TABLE 206. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 208. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 210. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 212. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 252. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2032 (USD MILLION)
  • TABLE 254. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 256. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 258. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 260. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 262. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 264. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 265. AFRICA ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 266. AFRICA ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. AFRICA ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. AFRICA ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 269. AFRICA ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2032 (USD MILLION)
  • TABLE 270. AFRICA ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2032 (USD MILLION)
  • TABLE 271. AFRICA ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 272. AFRICA ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 273. AFRICA ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2032 (USD MILLION)
  • TABLE 274. AFRICA ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 275. AFRICA ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 276. AFRICA ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 277. AFRICA ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 278. AFRICA ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 279. AFRICA ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 280. AFRICA ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 281. AFRICA ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2032 (USD MILLION)
  • TABLE 287. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2032 (USD MILLION)
  • TABLE 288. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 293. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 294. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 295. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 296. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 297. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 298. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 299. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 300. ASEAN ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 301. ASEAN ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. ASEAN ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. ASEAN ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 304. ASEAN ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2032 (USD MILLION)
  • TABLE 305. ASEAN ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2032 (USD MILLION)
  • TABLE 306. ASEAN ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 307. ASEAN ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 308. ASEAN ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2032 (USD MILLION)
  • TABLE 309. ASEAN ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 310. ASEAN ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 311. ASEAN ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 312. ASEAN ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 313. ASEAN ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 314. ASEAN ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 315. ASEAN ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 316. ASEAN ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 317. GCC ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 318. GCC ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. GCC ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 320. GCC ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 321. GCC ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2032 (USD MILLION)
  • TABLE 322. GCC ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2032 (USD MILLION)
  • TABLE 323. GCC ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 324. GCC ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 325. GCC ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2032 (USD MILLION)
  • TABLE 326. GCC ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2032 (USD MILLION)
  • TABLE 327. GCC ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 328. GCC ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 329. GCC ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 330. GCC ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 331. GCC ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 332. GCC ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 333. GCC ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 334. EUROPEAN UNION ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 335. EUROPEAN UNION ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2032 (USD MILLION)
  • TABLE 336. EUROPEAN UNION ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 337. EUROPEAN UNION ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2032 (USD MILLION)
  • TABLE 338. EUROPEAN UNION ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2032 (USD MILLION)
  • TABLE 339. EUROPEAN UNION ALPHA EMITTERS MARKET SIZE,